# Study of Tozuleristide and the Canvas Imaging System in Pediatric Subjects With CNS Tumors Undergoing Surgery

> **NCT03579602** · PHASE2,PHASE3 · COMPLETED · sponsor: **Blaze Bioscience Inc.** · enrollment: 118 (actual)

## Conditions studied

- Pediatric Central Nervous System Tumor

## Interventions

- **DRUG:** tozuleristide
- **DEVICE:** Canvas System

## Key facts

- **NCT ID:** NCT03579602
- **Lead sponsor:** Blaze Bioscience Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-26
- **Primary completion:** 2022-04-01
- **Final completion:** 2022-06-13
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2024-06-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03579602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03579602, "Study of Tozuleristide and the Canvas Imaging System in Pediatric Subjects With CNS Tumors Undergoing Surgery". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03579602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*